• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

Asean Breaking News

Update latest Asean news

  • About Us
  • Privacy Policy
  • Disclaimers
  • DMCA
  • Contact Us
  • Submit your story

You are here: Home / Archives for Sanofi regeneron

Sanofi regeneron

Sanofi and Regeneron’s Dupixent gets more positive feedback from US FDA: companies

November 5, 2018 channelnewsasia Leave a Comment

Health The U.S. Food & Drug Administration (FDA) regulator gave more positive feedback on the Dupixent eczema treatment being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday. 06 Nov 2018 02:30PM Bookmark PARIS: The U.S. Food & Drug Administration (FDA) regulator gave more positive feedback on the Dupixent eczema treatment being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday.The two firms said the FDA had accepted for a priority Review the supplemental Biologics License Application for Dupixent in adolescents aged 12 to 17 with moderate-to-severe atopic dermatitis whose disease was inadequately controlled with "topical therapies" or for whom such treatment was medically inadvisable.Dupixent was launched in the United States in April 2017 for the treatment of moderate-to-severe eczema in adults, and the product is seen as a key sales driver for both Sanofi and Regeneron.(Reporting by Sudip Kar-Gupta; editing by … [Read more...] about Sanofi and Regeneron’s Dupixent gets more positive feedback from US FDA: companies

Health sanofi regeneron, positive feedback examples, positive feedback mechanism, positive feedback system, positives feedback geben beispiele, providing positive feedback, providing positive feedback examples, how to provide positive feedback, examples of positive feedback, positive feedback examples for colleague, key positions in a company, positions in a company, top positions in a company, positions of a company, positions in a company from highest to lowest, company positions, company top positions, positions company, company bankrupt who gets paid first, company goes bankrupt who gets paid first, regeneron sanofi, regeneron and sanofi, positive 360 feedback examples, Get Lifted Film Company, fda warning letters pharmaceutical companies, positive upward feedback examples, Regeneron, medical health, Sanofi


Sanofi drug Dupixent wins FDA approval to treat asthma

October 20, 2018 channelnewsasia Leave a Comment

REUTERS: France's Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration as an additional maintenance therapy in patients with two types of asthma.Dupixent, co-developed with U.S.-based Regeneron, received approval to treat patients with eosinophilic asthma, a rare form of the disease, and those dependent on anti-inflammatory steroids.The drug acts by restraining proteins responsible for the inflammation of airways of the lungs, the root cause of asthma.Dupixent was launched in the United States in April 2017 for the treatment of moderate-to-severe eczema in adults.The drug, a key revenue driver for Sanofi, had worldwide sales of 176 million euros (US$202.5 million) in the second quarter of 2018, of which 151 million euros came from the United States.The drugmaker is also co-developing Dupixent for at least seven other conditions including pediatric asthma, chronic sinus infection with nasal polyps, and adolescent eczema.(Reporting by … [Read more...] about Sanofi drug Dupixent wins FDA approval to treat asthma

Health fda approves cancer drug, fda approved drugs 2016, fda approved drugs 2017, fda approved drugs, fda approved drugs for weight loss, new fda approved drugs, fda approves new weight loss drug, fda approves new cancer drug, fda approves new breast cancer drug, fda approves new ms drug, accelerated approval fda, drug at fda, fda drugs, drugs at fda, fda approved drugs 2015, drugs approved, newly approved drugs, approved drug products with therapeutic equivalence evaluations, drug approvals, fda most dangerous drugs list, treat drug addiction, treating drug addiction, drug to treat addiction, newly approved chemotherapy drugs, asthma can be treated with antibiotics, hologic tomosynthesis fda approval, drugs used to treat schizophrenia, treat asthma, FDA, United States, medical health, asthma, France

Sanofi, Regeneron skin cancer drug gets FDA nod

September 29, 2018 channelnewsasia Leave a Comment

Health Sanofi SA said on Friday its skin cancer drug, made in partnership with Regeneron Pharmaceuticals Inc, was approved by the U.S. Food and Drug Administration. 29 Sep 2018 05:15AM Bookmark REUTERS: Sanofi SA said on Friday its skin cancer drug, made in partnership with Regeneron Pharmaceuticals Inc, was approved by the U.S. Food and Drug Administration.The drug, Libtayo, is used to treat skin cancer in patients whose condition has not improved following surgery or chemotherapy.Libtayo will be sold in the United States at a list price of US$9,100 for a three-week treatment cycle.(Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Shounak Dasgupta) … [Read more...] about Sanofi, Regeneron skin cancer drug gets FDA nod

Health new cancer drug approved by fda, fda approves cancer drug, fda cancer drug approvals, fda approves new cancer drug, fda approves new breast cancer drug, sanofi regeneron, pfizer cancer drug approved by fda, fda cancer drug, fda cancer drug approval, skin cancer how do you get it, drug at fda, drugs at fda, clinical cancer drugs impact factor, fda drugs, getting hair dye off skin, best prescription drugs to get high, best drugs to get high, getting under my skin, gets under my skin, bc cancer agency drug manual, fda approves new ms drug, astrazeneca lung cancer drug, immunotherapy skin cancer, immunotherapy lung cancer drugs, immune cancer drugs, astrazeneca ovarian cancer drug, pfizer breast cancer drug, chemotherapy drugs for lung cancer, fda approves new weight loss drug, skin cancer, FDA, medical health, Sanofi

Latecomer Sanofi looks to catch next wave of cancer therapies

June 19, 2018 channelnewsasia Leave a Comment

PARIS: Sanofi missed the boat on immune system-boosting cancer drugs. Now it's trying to catch up.The French drugmaker has hired John Reed, the former top scientist at oncology market leader Roche to head its group research operations. And it is now focusing on a pipeline of 10 medicines that it hopes will help it get a piece of the US$100 billion-a-year cancer drug market.Dmitri Wiederschain, head of Sanofi's immuno-oncology research, acknowledged the company had failed to capitalize on the takeoff of immunotherapy - drugs that activate the body's immune system to attack tumor cells - in the early 2010s.But he said the group could now gain an edge in the next waves of immunotherapy treatments, which include combining different drugs to better target cancer."It is of course a very competitive space but we now have 'foundation assets' to form a better rationale for combinations," he told Reuters in an interview, citing immunotherapy approaches known as PD-1, TGFBeta and the antibody … [Read more...] about Latecomer Sanofi looks to catch next wave of cancer therapies

Health catching wave, catching waves, catch wave, can you catch cervical cancer, brain waves sound therapy, breast cancer therapy, alternative cancer therapy, breast cancer therapies, cancer therapy, natural cancer therapy, how does cancer look like, catch the wave, Catching the Wave, surfing how to catch a wave, what does cancer look like, current cancer therapy reviews, what does testicular cancer look like pictures, maintenance therapy cancer, cancer maintenance therapy, maintenance therapy for lung cancer, lung cancer maintenance therapy, hormonal therapy for breast cancer, disruptive technologies catching the wave, why hormone therapy for prostate cancer, biological cancer therapy, cancer hormone replacement therapy, t cell therapy for breast cancer, Regeneron, John Reed, brain tumor, Elias Zerhouni, Sanofi, health & fitness

European Medicines Agency to review Sanofi-Regeneron’s Dupixent, Cemiplimab

April 2, 2018 robert Leave a Comment

Health The European Medicines Agency (EMA) will review the Dupixent (dupilumab) and Cemiplimab products being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday. 03 Apr 2018 01:30PM Bookmark PARIS: The European Medicines Agency (EMA) will review the Dupixent (dupilumab) and Cemiplimab products being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday.They said the EMA had accepted to review an application for Dupixent as an add-on maintenance treatment in certain adults and adolescents with inadequately controlled moderate-to-severe asthma.They said the EMA had also accepted to review the marketing authorization application (MAA) for Cemiplimab, which is used to treat patients with metastatic cutaneous squamous cell carcinoma (CSCC) - a form of skin cancer - or patients with locally advanced CSCC who are not candidates for surgery.(Reporting by Sudip Kar-Gupta; Editing by Subhranshu Sahu) … [Read more...] about European Medicines Agency to review Sanofi-Regeneron’s Dupixent, Cemiplimab

Health european union agency for fundamental rights, European travel agencies, European Intelligence Agency, medicines agency, european defence agency, European Pressphoto Agency, european railway agency, emergency medicine board review, model management agency reviews, european wax center reviews, european foreign affairs review, european constitutional law review, medicine use review, medicines use review, european journal of internal medicine, European Society of Intensive Care Medicine, european journal of medicinal chemistry, medicines control agency, agency management system reviews, agency 2.0 review, agency management system reviews and comparisons, foreign investment review agency, osteopathic family medicine board review, board review internal medicine, internal medicine board review, absolute best care nanny agency reviews, surrogacy agency reviews

Next Page »

Primary Sidebar

Categories

Asia Backstage Bacolod Basketball Breaking News Business Business News Canada Career Cebu Davao Entertainment Featured Columns Finance GTA Headlines Health Inside News Instagram Life Lifestyle Litra-Talk Bansa Probinsiya Metro Opinyon Palaro Showbiz True Confessions Dr. Love Kutob Komiks local Luzon Manila Metro Mindanao National News Opinion Opinions and Editorials Other Sports Overseas Provincial Queen's Park Singapore sport Sports Tech Insider Technology Today's Headline Photos Travel Uncategorized Weekly World

Recent Posts

  • News Macron, Putin weigh ‘deteriorated’ situation in Syria
  • News Karl Marx memorial vandalized in London for second time
  • News Thousands mark 3 months of France’s ‘yellow vest’ protests
  • News Saudi defends app allowing men to monitor women relatives
  • News UK airline flybmi collapses under fuel costs, Brexit pressures
  • News UK’s May to speak to every EU leader in bid to break Brexit deadlock
  • News LeBron says owning NBA club ‘would have to be right fit’
  • Di Grassi seizes Mexico Formula E win at the line
  • News Babaeng ‘tulak’ arestado sa QC
  • News Nasa 30 pamilya, nawalan ng bahay sa sunog sa Maynila

Copyright © 2019 Asean Breaking News. Power by Wordpress.